Supplemental Materials
Downloadable Files:
- Printable Powerpoint slides (PDF) (2.5 MB)
- Audio Transcripts (PDF) (94 KB)
Question and Answer Session:
Recommended Websites:
- Centers for Disease Control, Division of Tuberculosis Elimination
- International Union Against Tuberculosis and Lung Disease
- National Tuberculosis Controllers Association
Recommended Readings:
- American Thoracic Society/ Centers for Disease Control and Prevention/ Infectious Diseases Society of America: Treatment of Tuberculosis. MMWR. June 20, 2003; 52(RR11): 1-77.
- Guidelines for the Treatment of Tuberculosis and Tuberculosis Infection for California, CDHS/ CTCA Joint Guidelines
- Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Mommucleoside Reverse Transcriptase Inhibitors. MMWR. 2000; 49(9):13-17.
- The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. N Engl J Med 1994 Apr 28;330(17):1179-84.
- Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Chang KC; Leung CC; Yew WW; Chan SL; Tam CM; Am J Respir Crit Care Med. 2006 Nov 15;174(10):1153-8. Epub 2006 Aug 14.